Adenosine Triphosphate (ATP) Swab Test Market to Hit 8.2% CAGR from 2020 to 2027 | Hygiena, Kikkoman Biochemifa, Neogen, Luminultra Technologies, Charm Sciences

January 29 17:50 2021
Adenosine triphosphate (ATP) swab test market is expected to reach US$ 369.71 million by 2027 from US$ 198.21 million in 2019; the market is estimated to grow at a CAGR of 8.2% from 2020 to 2027.

According to our new market research study on “Adenosine Triphosphate (ATP) Swab Test Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type and Application,” the market is expected to reach US$ 369.71 million by 2027 from US$ 198.21 million in 2019; it is estimated to grow at a CAGR of 8.2% from 2020 to 2027. The report highlights trends prevailing in the global adenosine triphosphate (ATP) swab test market, and the drivers and restraints pertaining to the market growth.

Based on type, the adenosine triphosphate (ATP) swab test market is segmented into free ATP test and microbial ATP test. In 2019, the microbial ATP test segment held the largest share of the market. The same segment is expected to grow at the faster rate during the forecast period. Microbial ATP hygiene monitoring provides a measurement of the direct risks resulting from high levels of microorganisms plus the unintended risks resulting from organic scums that can offer a source of nutrients to microorganisms. Such effective hygienic monitoring is likely to accelerate the growth of the market.

Request For Exclusive Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00014433/

Hygiena, Llc; 3M; Charm Sciences, Inc.; Kikkoman Biochemifa; Neogen; Ecolab; Ruhof Healthcare Corporation; Luminultra Technologies Ltd.; and Merck KGaA are among the leading companies operating in the adenosine triphosphate (ATP) swab test market.

The ATP test is the fast calculation by identification of adenosine triphosphate or ATP of aggressively developing microorganisms. ATP is a molecule in and near living cells that specifically tests the biological production and wellbeing of the organisms. ATP is determined with the natural fire enzyme luciferase by using a luminometer to calculate the light emitted by its reaction. The global adenosine triphosphate (ATP) swab test market growth is mainly attributed to factors such as rising prevalence of healthcare-associated infections and increasing emphasis on food safety. However, limitations of ATP swab tests hinder the market growth.

The global adenosine triphosphate (ATP) swab test market growth is mainly attributed to factors such as rising prevalence of healthcare-associated infections and increasing emphasis on food safety. However, limitations of ATP swab tests hinder the market growth.

Rising prevalence of HAIs is one of the prominent factors, which is driving the demand for adenosine triphosphate. For instance, according to a study published by the Centers for Disease Control and Prevention in 2019, an estimated 1 in 31 hospital patients has some kind of healthcare-associated infection. In addition, according to estimates given by The European Centre for Disease Prevention and Control in 2019, around 4.1 million patients across Europe suffer due to healthcare-associated infections each year. Furthermore, according to study published in journal of Antimicrobial Resistance & Infection Control in 2019, the incidence rate of HAIs in China was 3.62 per 1,000 patient days. Out of this rate of incidence, respiratory tract infection accounted for 43.80% of infections while bloodstream and urinary tract infections accounted for 15.74% and 12.69% of infections, respectively. Such substantial prevalence of healthcare-associated infections is anticipated to have a positive impact on the adoption of ATP swab test, which would eventually drive the market.

Reasons to Buy:

  1. The nature of Adenosine Triphosphate (ATP) Swab Test business opportunities has grown in complexity with the industry evolving at a greater pace, making it increasingly difficult going without adequate information on markets and companies.
  2. Gain a complete understanding of Global Adenosine Triphosphate (ATP) Swab Test industry through the comprehensive analysis
  3. Evaluate the pros and cons of investing/operating in country level Adenosine Triphosphate (ATP) Swab Test markets through reliable forecast model results
  4. Identify potential investment/contract/expansion opportunities
  5. Drive your strategies in the right direction by understanding the impact of latest trends, market forecasts on your Adenosine Triphosphate (ATP) Swab Test business
  6. Beat your competition through information on their operations, strategies and new projects
  7. Recent insights on the Adenosine Triphosphate (ATP) Swab Test market will help users operating in the market to initiate transformational growth

Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00014433/

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]

Media Contact
Company Name: The Insight Partners
Contact Person: Sameer Joshi
Email: Send Email
Phone: +1-646-491-9876
City: Pune
State: Maharashtra
Country: India
Website: https://www.theinsightpartners.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/ghaziabadonline/faridabadonlinejournal.in/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7